ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3201

Diagnostic Value of Quantitative Sialoscintigraphy Compared to Labial Salivary Gland Biopsy in Patients with Suspected SjöGren’ Syndrome

Maria Garcia-Gonzalez1, Maria Jesus Gonzalez-Soto2, Ivan Ferraz-Amaro1, Hiurma Sanchez1, Vanesa Hernandez1, Maria Angeles Gomez2 and Sagrario Bustabad1, 1Rheumatology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain, 2Nuclear Medicine, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Sjogren's syndrome and diagnosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Imaging of Rheumatic Diseases III: Crystal Arthritis, Osteoarthritis, Connective Tissue Disease and Vasculitis

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Salivary gland dysfunction is one of the most common features of Sjögren’ syndrome (SS). Sialoscintigraphy (sSC) is the only technique nowadays available to objectify salivary gland dysfunction that provides simultaneous information about type of functional defect, distribution and severity. In recent years its interpretation based mainly on qualitative indices and the appearance of the ACR criteria have shifted in favor of the biopsy (Bp). Some studies have analyzed the role of quantitative scintigraphic indices, mainly excretion fraction (EF%), in the diagnosis of SS, with mixed results. In our study we aimed to describe glandular involvement patterns and EF% values useful in SS diagnosis and to compare diagnostic accuracy of scintigraphic indices and Bp.

Methods: Patients with suspected SS and with sSC and Bp performed between 2006-2012 were included. sSC were performed in a 30 minutes protocol with 99mTc sodium pertechnetate and lemon juice stimulation. Patients already diagnosed of SS and/or with sSC or Bp requested by specialists other than rheumatologists were excluded. Correlations between glandular involvement patterns and EF% and diagnosis of SS were analyzed with Fisher exact test and Kruskal Wallis respectively. Sensitivity, specificity and receiver operating characteristic curve analysis of scintigraphic indices and Bp were performed.

Results: Among 272 patients with sSC performed in that period, 71 fulfilled inclusion criteria. Sixty-eight (96%) were women with a mean age of 52 ± 14 in the timing of sSC. Fifty-seven (80%) reported xerostomia, the majority (39%) with onset in recent months. Qualitative sSC were reported as abnormal in 51 cases (71%); data on age, xerostomia duration, xerostomia related drugs and presence of thyroid disease showed similar frequencies among normal and abnormal sSC groups. Sufficient data to apply American-European Consensus Group and ACR criteria were available in 69 and 48 patients respectively, with diagnosis of SS in 38 (54%). Uptake dysfunction (96 vs 77% p 0.134) and submandibular involvement (59 vs 30% p 0.236) were observed most frecuently in SS patients. All glands showed lower EF% medians in this group, with significant differences for submandibulary ones: right gland 29 (7-37) vs 49 (41-57) p 0.004; left gland 30 (10-45) vs 52 (29-64) p 0.007. Submandibular EF% (right gland AUC 0.793 ± 0.091 p 0.004 IC 95% [0.61-0.97]; left gland AUC 0.764 ± 0.083 p 0.007 IC 95% [0.60-0.93]) showed better diagnostic accuracy than qualitative sSC (AUC 0.601 ± 0.070 p 0.149 IC 95% [0.47-0.74]) and similar to Bp (AUC 0.789 ± 0.055 p 0.000 IC 95% [0.68-0.90]). Cutoff values of 39.5 (right gland) and 47.5 (left gland) of submandibular EF% showed a sensitivity of 95-82% and specificity of 71-67%, compared to 82% and 39% for qualitative sSC, and 58% and 100% for Bp.

Conclusion: 1) Patients fulfilling SS criteria show lower submandibular EF% compared to those who do not. 2) Diagnostic accuracy of submandibular EF% is better than qualitative sSC and similar to Bp. 3) Cutoff values of submandibular EF% of 39.5 (right gland) and 47.5 (left gland) show a sensitivity comparable to qualitative sSC but a significantly higher specificity.


Disclosure: M. Garcia-Gonzalez, None; M. J. Gonzalez-Soto, None; I. Ferraz-Amaro, None; H. Sanchez, None; V. Hernandez, None; M. A. Gomez, None; S. Bustabad, None.

To cite this abstract in AMA style:

Garcia-Gonzalez M, Gonzalez-Soto MJ, Ferraz-Amaro I, Sanchez H, Hernandez V, Gomez MA, Bustabad S. Diagnostic Value of Quantitative Sialoscintigraphy Compared to Labial Salivary Gland Biopsy in Patients with Suspected SjöGren’ Syndrome [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/diagnostic-value-of-quantitative-sialoscintigraphy-compared-to-labial-salivary-gland-biopsy-in-patients-with-suspected-sjogren-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-value-of-quantitative-sialoscintigraphy-compared-to-labial-salivary-gland-biopsy-in-patients-with-suspected-sjogren-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology